This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Opinion/comment
Opinion/comment
IV immunoglobulins: what pharmacists should know
Working the SMART way
Big data to support a better hospital pharmacy service
Dose banding: the end of compounding?
BLOG: The best job in the world?
CHMP issues a positive opinion on Janssen’s single-agent DARZALEX® (daratumumab)
Janssen receives CHMP positive opinion for TREVICTA® for treatment of schizophrenia
Sobi and Biogen receive positive opinion from CHMP for Alprolix® for the treatment of haemophilia B
BLOG: The evolving role of a pharmacy technician
Hospital pharmacists’ contribution: a perspective
Amgen receives CHMP positive opinion for IMLYGIC (TM) (talimogene laherparepvec)
Bedside manner: not just for doctors any more*
« Previous
1
…
5
6
7
8
9
…
21
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: